Drug Information Association Logo
Corporate Tagline

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    The Use of Mobile Medical Applications as Companions Apr 20, 2014 Online Instruction Global Online
    Regulating a Social World Apr 20, 2014 Online Instruction Global Online
    English Literacy and Spanish Transcreation of Patient Documents: Concepts for Low Literacy Materials Apr 20, 2014 Online Instruction Global Online
    Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Apr 20, 2014 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions Apr 20, 2014 Online Instruction Global Online
    Safety and Social Media: Is this the Question or the Answer Apr 20, 2014 Online Instruction Global Online
    Complimentary Patient-Centeredness and Engagement in Clinical Research: Opportunities for Industry Apr 20, 2014 Online Instruction Global Online
    Aligning the Voices of Change in the Health Care System Apr 20, 2014 Online Instruction Global Online
    Evaluation and Management of Cardiac Conditions in Oncology Patients Apr 20, 2014 Online Instruction Global Online
    Risk Management of Medicinal Products: REMS and RMP - Need for Harmonization Within the ICH Region? Apr 20, 2014 Online Instruction Global Online
    A Closer Look at FDASIA Provisions to Promote Biomedical Innovation Apr 20, 2014 Online Instruction Global Online
    CDER Town Meeting: Safety Hot Topics Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series - Part 1: Introduction to the Benefit-Risk - Why is Everyone Talking about Benefit-Risk? Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series Part 2 - Benefit-Risk Assessment a Changing Regulatory Landscape Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series - Part 3: Framing for Benefit-Risk Assessment and Communication Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series - Part 4: Clinical Judgment and Pragmatic Considerations for Endpoint Selection and Display in Benefit-Risk Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series- Part 5: Stated Choice Methods for Valuing Benefits and Risks Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series-Part 6: Multi-criteria Decision Analysis to Assist in the Decision Making Process Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series- Part 7: A Structured, Quantitative Health Outcomes Approach to Drug Benefit-Risk Analysis Apr 20, 2014 Online Instruction Global Online
    Assessing the Benefits and Risks of Medicines: Webinar Series- Part 8: Visualization and Communication of Benefit-Risk Apr 20, 2014 Online Instruction Global Online
    Practical Aspects and Examples of Using Large Datasets for Investigating Product Safety and Effectiveness in the US and EU Apr 20, 2014 Online Instruction Global Online
    New Good Pharmacovigilance Practice (GVP) Documents in Canada Apr 20, 2014 Online Instruction Global Online
    Complimentary Biomarker Strategies for More Efficient Early-Phase Drug Development in Alzheimer's Disease Apr 20, 2014 Online Instruction Global Online
    Using Patient-Reported Outcomes to Assess Product Safety and Tolerability: Methodological and Regulatory Considerations Apr 20, 2014 Online Instruction Global Online
    CardioVascular Safety: The New Paradigm - Proarrhythmic Assessment of New Drugs without the Thorough QT Study Apr 20, 2014 Online Instruction Global Online
    CardioVascular Safety – What are the Key Issues Regarding Blood Pressure Assessment During Clinical Development Apr 20, 2014 Online Instruction Global Online
    Electronic Submissions 101 – Essential MS Word and Adobe Acrobat Tools/Skills and Current IT Options Apr 20, 2014 Online Instruction Global Online
    EDM and ERS/eCTD: Impact of e-Initiatives on Content and Context: FDA Update/Progress Report Apr 20, 2014 Online Instruction Global Online
    Regulatory and Legal Landscape Impacting Medical and Scientific Communications Apr 20, 2014 Online Instruction Global Online
    Measurement in Clinical Trials: An Examination of the FDA Position on Review of Clinical Outcome Assessments (COAs) Apr 20, 2014 Online Instruction Global Online
    The Electronic Trial Master File: So Much More than Just a Secure Document Repository Apr 20, 2014 Online Instruction Global Online
    Planning and Implementing Large Cardiovascular Outcomes Studies: Opportunities & Challenges Apr 20, 2014 Online Instruction Global Online
    Press the Easy Button – Ensure Consistency and Compliance for your Documents through Automation Apr 20, 2014 Online Instruction Global Online
    When Outsourcing Stops Making Sense Apr 20, 2014 Online Instruction Global Online
    Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Apr 20, 2014 Online Instruction Global Online
    Drug & Cosmetic Rule Amendments: Changes in Regulations Governing Clinical Trials in India Apr 20, 2014 Online Instruction Global Online
    A Regulatory Perspective of Biosimilars in Emerging Markets Apr 20, 2014 Online Instruction Global Online
    Combination Products and Convergence: An Overview of Clinical Benefits, Regulatory Issues & Manufacturing Challenges Apr 20, 2014 Online Instruction Global Online
    Social and Collaborative Tools in Regulatory Intelligence Apr 20, 2014 Online Instruction Global Online
    Certificates of Pharmaceutical Products for Regulatory Submissions Apr 20, 2014 Online Instruction Global Online
    FDASIA Year in Review Apr 20, 2014 Online Instruction Global Online
    The Case of the New England Compounding Center: Learning from the Tragedy Apr 20, 2014 Online Instruction Global Online
    The Future of Personalized Medicine and Companion Diagnostics Apr 20, 2014 Online Instruction Global Online
    Two-part Webinar Series: Impact of the New European Pharmacovigilance Legislation and Important Updates Apr 20, 2014 Online Instruction Global Online
    FDA and the Freedom of Information Act: The Unredacted Story Apr 20, 2014 Online Instruction Global Online
    The Current State of Quality Oversight (QO) in the Pharmaceutical Industry Apr 20, 2014 Online Instruction Global Online
    Combination Product Premarket Considerations Apr 20, 2014 Online Instruction Global Online
    Utilizing the 505(b)(2) Pathway to Streamline and Accelerate a Drug Development Plan Apr 20, 2014 Online Instruction Global Online